Total Payments
$437,164
2024 Payments
$20,675
Companies
54
Transactions
1,647
Medicare Patients
9,347
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$319,490 (73.1%)
Travel$87,069 (19.9%)
Food & Beverage$26,260 (6.0%)
Consulting$4,250 (1.0%)
Education$94.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $291,014 | 162 | 66.6% |
| Travel and Lodging | $87,069 | 313 | 19.9% |
| Honoraria | $28,476 | 17 | 6.5% |
| Food and Beverage | $26,260 | 1,151 | 6.0% |
| Consulting Fee | $4,250 | 2 | 1.0% |
| Education | $94.08 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $172,093 | 211 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $63,823 | 245 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $46,165 | 72 | $0 (2018) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36,501 | 63 | $0 (2021) |
| Allergan, Inc. | $19,968 | 74 | $0 (2020) |
| UROVANT SCIENCES INC | $18,943 | 43 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $17,683 | 27 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $17,573 | 34 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $13,253 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11,135 | 67 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,675 | 140 | Otsuka America Pharmaceutical, Inc. ($17,498) |
| 2023 | $13,260 | 132 | Sumitomo Pharma America, Inc. ($11,800) |
| 2022 | $16,974 | 175 | UROVANT SCIENCES INC ($15,050) |
| 2021 | $19,866 | 123 | SUN PHARMACEUTICAL INDUSTRIES INC. ($14,642) |
| 2020 | $8,869 | 78 | Sun Pharmaceutical Industries Inc. ($8,287) |
| 2019 | $68,501 | 223 | Janssen Pharmaceuticals, Inc ($27,760) |
| 2018 | $123,889 | 336 | Janssen Pharmaceuticals, Inc ($47,270) |
| 2017 | $165,130 | 440 | Janssen Pharmaceuticals, Inc ($96,980) |
All Payment Transactions
1,647 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Obesity | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,166.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $859.37 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Hematology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $40.01 | General |
| Category: PSYCHIATRY | ||||||
| 11/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $1,223.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $171.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,508.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $13.40 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,667 | 4,612 | $591,962 | $302,601 |
| 2022 | 32 | 2,517 | 5,466 | $592,175 | $292,250 |
| 2021 | 31 | 2,467 | 4,723 | $549,215 | $268,017 |
| 2020 | 28 | 1,696 | 3,556 | $347,040 | $164,157 |
Total Patients
9,347
Total Services
18,357
Medicare Billing
$1.0M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 605 | $114,970 | $54,459 | 47.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 123 | 359 | $61,380 | $30,299 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 441 | $55,125 | $27,967 | 50.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 167 | 175 | $54,765 | $25,244 | 46.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 119 | 382 | $49,500 | $22,453 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 173 | 173 | $36,710 | $22,435 | 61.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 190 | 194 | $22,260 | $14,715 | 66.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 62 | 175 | $29,820 | $14,020 | 47.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 31 | 273 | $21,840 | $10,500 | 48.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 92 | 97 | $19,565 | $10,193 | 52.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 153 | 167 | $19,205 | $10,140 | 52.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 44 | 148 | $19,225 | $8,465 | 44.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $9,300 | $8,463 | 91.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 32 | 211 | $13,715 | $7,996 | 58.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 98 | 99 | $8,910 | $7,111 | 79.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 32 | 44 | $10,730 | $4,627 | 43.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 118 | 119 | $4,765 | $3,688 | 77.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 29 | 111 | $6,105 | $3,478 | 57.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $4,675 | $2,439 | 52.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 118 | 118 | $2,985 | $2,152 | 72.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,900 | $2,095 | 72.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 166 | 181 | $5,430 | $1,985 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 143 | $4,290 | $1,433 | 33.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 43 | 47 | $2,820 | $1,240 | 44.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 63 | 63 | $1,890 | $1,114 | 59.0% |
About Dr. Jeffrey Deitch, DO
Dr. Jeffrey Deitch, DO is a Family Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386634749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Deitch, DO has received a total of $437,164 in payments from pharmaceutical and medical device companies, with $20,675 received in 2024. These payments were reported across 1,647 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($291,014).
As a Medicare-enrolled provider, Deitch has provided services to 9,347 Medicare beneficiaries, totaling 18,357 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Sterling Heights, MI
- Active Since 10/26/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386634749
Products in Payments
- XARELTO (Drug) $172,072
- LONHALA MAGNAIR (Drug) $40,898
- BEVYXXA (Drug) $34,517
- GEMTESA (Drug) $32,258
- UTIBRON (Drug) $22,504
- DRIZALMA SPRINKLE (Drug) $19,658
- Xtampza ER (Drug) $17,683
- REXULTI (Drug) $17,664
- EZALLOR SPRINKLE (Drug) $15,365
- ANDEXXA (Drug) $11,648
- NAMZARIC (Drug) $10,085
- DALVANCE (Drug) $5,580
- YOSPRALA (Drug) $5,124
- AUSTEDO (Drug) $5,032
- LINZESS (Drug) $4,072
- KAPSPARGO (Drug) $1,478
- Ozempic (Drug) $640.96
- Victoza (Drug) $439.58
- NUEDEXTA (Drug) $388.72
- ENTRESTO (Drug) $386.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sterling Heights
Dr. Steven Margolis, Md, MD
Family Medicine — Payments: $475,760
Family Medicine $475,760
Mark Rosenberg, Do, DO
Family Medicine — Payments: $17,360
Family Medicine $17,360
Dr. Kenneth Wolok, Do, DO
Family Medicine — Payments: $14,456
Family Medicine $14,456
Steven Hudock, Md, MD
Family Medicine — Payments: $11,839
Family Medicine $11,839
Dr. Stuart Stoller, D.o, D.O
Family Medicine — Payments: $10,416
Family Medicine $10,416
Dr. Fredric Neumann, D.o, D.O
Family Medicine — Payments: $10,046
Family Medicine $10,046